Medicare seeks to ensure Americans over age 65, and younger people with certain disabilities, have affordable health care. This Federal health insurance program is particularly important for our community, as colon cancer disproportionately impacts older adults. Most people are familiar with Medicare Part D, which provides coverage for prescription drugs patients buy at the pharmacy; lesser known is Part B, which covers prescription drugs administered in a physician’s office or hospital outpatient department, such as most medications that treat colon cancer.
On March 8, the Centers for Medicare and Medicaid Services (CMS) announced a proposed rule to test changes to Part B coverage. Acting Administrator for CMS Andy Slavitt said, “These proposals would allow us to test different ways to help Medicare beneficiaries get the right medication and right care…this is consistent with our focus on testing value-based care models.” The CMS-proposed tests come in two phases: the first changes how physicians are reimbursed under Part B and will start later this year, while the second will test a variety of pricing strategies in 2017.